BioDelivery Sciences International, a specialty pharmaceutical company, has appointed Thomas W. D'Alonzo to the company's board of directors.
Previously, D'Alonzo served on the BDSI board of directors from August 2006 through June 2008. He has held numerous high-level executive positions and board appointments within both large and specialty pharmaceutical companies. D'Alonzo has been a member of the board of directors at Salix Pharmaceuticals since May 2000 and chairman of the board since June 2010. He has also previously served on the board of directors of Plexigen, DARA BioSciences and Amarillo Biosciences.
D'Alonzo's extensive pharmaceutical industry background also includes a number of executive positions, including CEO at biotechnology companies DARA BioSciences and GenVec, and president and COO at PPD. Early in his career and over a 10 year period, he held positions of increasing responsibility within Glaxo, the U.S. division of GlaxoSmithKline, including serving as president from 1988 to 1993. D'Alonzo has also been an independent pharmaceutical industry consultant for a number of years.